Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority ...
Bernstein SocGen Group has revised its price target for Merck (NYSE:MRK) shares, bringing it down to $95 from the previous $110 while maintaining a Market Perform rating. Analyst Courtney Breen cited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback